BioNTech/Pfizer vaccine is less potent against South African variant
Published
Covid-19 jab still works but produces only a third of the antibodies it did for original virus, study finds
Full ArticlePublished
Covid-19 jab still works but produces only a third of the antibodies it did for original virus, study finds
Full ArticlePfizer Inc and BioNTech SE are in talks with regulatory authorities about testing a vaccine modified to protect specifically..
The company is proposing to do a Phase I clinical trial of a booster shot of that prototype vaccine that it would test against a..